Puma Biotechnology Competitors and Similar CompaniesClear all
Puma Biotechnology's competitors and similar companies include Ascendis Pharma.
 Puma Biotechnology Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer. |  Ascendis Pharma Ascendis Pharma is a biopharmaceutical company that specializes in endocrinology and oncology. | |
Founding Date | Founding Date 2010 | Founding Date 2007 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Los Angeles, US HQ | Locations Hellerup, DK HQ Heidelberg, DE Palo Alto, US |
Employees | Employees 27214% decrease | Employees 1,017 |
Valuation ($) | Valuation ($) 136.8 m | Valuation ($) 7.7 b |
Financial | ||
Revenue (est.) | Revenue (est.) $228.4m (FY, 2025) | Revenue (est.) €720.1m (FY, 2025) |
Cost of goods | Cost of goods $58.2m (FY, 2025) | Cost of goods €93.1m (FY, 2025) |
Gross profit | Gross profit $170.2m (FY, 2025) | Gross profit €627.1m (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 172m | Total funding raised $ 85.8m |
For sources of this data, please see the company profile
View Company Profiles
Ascendis Pharma
HQ
Hellerup, DK
Employees
1,017
Ascendis Pharma is a biopharmaceutical company that specializes in endocrinology and oncology.
View company